Staging and Survival in Gynecologic Malignancies
| Stage | Ovarian | 5-Year Survival, % | Endometrial | 5-Year Survival, % | Cervical | 5-Year Survival, % |
|---|---|---|---|---|---|---|
| 0 | — | — | Carcinoma in situ | 100 | ||
| I | Confined to ovary | 90-95 | Confined to corpus | 89 | Confined to uterus | 85 |
| II | Confined to pelvis | 70-80 | Involves corpus and cervix | 73 | Invades beyond uterus but not pelvic wall | 65 |
| III | Intra abdominal spread | 25-50 | Extends outside the uterus but not outside the true pelvis | 52 | Extends to pelvic wall and/or lower third of vagina, or hydronephrosis | 35 |
| IV | Spread outside abdomen | 1-5 | Extends outside the true pelvis or involves the bladder or rectum | 17 | Invades mucosa of bladder or rectum or extends beyond the true pelvis | 7 |